Journalists Explain Ramifications of Theranos Trial and Texas’ New Abortion Law
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Health Industry
1,421-1,440 of 4,029 results
-
-
Florida Spine Surgeon and Device Company Owner Charged in Kickback Scheme
Dr. Kingsley R. Chin and SpineFrontier were the subject of a recent KHN “Spinal Tap” investigation.
By Fred Schulte -
Lack of a Vaccine Mandate Becomes Competitive Advantage in Hospital Staffing Wars
After months of burnout from the pandemic, hospitals are scrambling to fill nursing and other jobs. Some administrators, particularly in rural areas, are afraid to implement vaccine mandates that alienate their short-handed staffs.
By Lauren Weber -
Jaw Surgery Takes a $27,119 Bite out of One Man’s Budget
A Seattle patient discovers the hard way that you can still hit a lifetime limit for certain types of care. And health plans can vary a lot from one job to the next, even if the insurer is the same.
-
KHN’s ‘What the Health?’: Vaccine Approval Moves the Needle on Covid
The FDA’s formal approval of the first vaccine to prevent covid-19 may or may not prompt doubters to go out and get shots, but it has clearly prompted employers to make vaccination a work requirement. Meanwhile, moderates and liberals in the U.S. House put aside their differences long enough to keep a giant social-spending bill on track, at least for now. Joanne Kenen of Politico, Tami Luhby of CNN and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest their favorite health policy stories of the week they think you should read, too.
-
Microbiome Startups Promise to Improve Your Gut Health, but Is the Science Solid?
A raft of startups are charging consumers hundreds of dollars to analyze the microbes in their gut and offer dietary advice based on the results. But scientists say scant research has been done, and as customers of one company have learned the hard way, the experience isn’t always smooth.
-
Mission and Money Clash in Nonprofit Hospitals’ Venture Capital Ambitions
Nonprofit hospitals of all sizes have been trying their luck as venture capitalists, saying their investments improve care through the creation of new medical devices, health software and other innovations. But the gamble at times has been harder to pull off than expected.
By Jordan Rau -
‘An Arm and a Leg’: Meet the Mississippi Lawyer Who Helped Start the Fight for Charity Care
The man famous for taking on Big Tobacco in the '90s, and winning, launched a series of ill-fated national lawsuits against nonprofit hospitals. This episode is the first in a series looking at the origins of charity care.
-
KHN’s ‘What the Health?’: Booster Time
As the delta variant continues to spread around the U.S., the Biden administration is taking steps to authorize covid vaccine boosters, require nursing home workers to be vaccinated and protect school officials who want to require masks despite state laws banning those mandates. Meanwhile, the U.S. House is returning from its summer break early to start work on its giant budget bill, which includes a long list of health policy changes. Alice Miranda Ollstein of Politico, Margot Sanger-Katz of The New York Times and Kimberly Leonard of Business Insider join KHN’s Julie Rovner to discuss these issues and more.
-
Apple Aims to Push More Patient Data to Doctors. But Who Can Gauge Its Impact on Health?
The Silicon Valley giant has been cryptic about its plan for the growing mound of health data available through its iPhones and watches. Health systems have experimented with the company’s health app, but it hasn’t yet become central to treatment.
By Sarah Kwon -
Surgeons Cash In on Stakes in Private Medical Device Companies
Doctors tied to professional sports teams share in investment bonanza.
By Fred Schulte -
Injuries Mount as Sales Reps for Device Makers Cozy Up to Surgeons, Even in Operating Rooms
Aggressive sales tactics have allegedly led surgeons to use defective or wrong-size implants, screws or other products on patients, including former Olympian Mary Lou Retton.
By Fred Schulte -
Hard Lessons From a City That Tried to Privatize Public Health
Facing bankruptcy, Detroit largely dismantled its public health department in 2012, and the city essentially went two years without a government-run public health system. Five years later, this major American city offers a grim cautionary tale.
-
Providence-KP Team Up to Attract Patients in California’s Growing High Desert Region
Providence, the country’s 10th-biggest hospital chain, says it’s too expensive to upgrade an older hospital, so it will join forces with giant Kaiser Permanente to build a new one.
-
A Health Care Giant Sold Off Dozens of Hospitals — But Continued Suing Patients
Community Health Systems, a large, for profit hospital chain, shrank from more than 200 to 84 facilities. It is continuing to sue patients for hospitals that now exist as little more than legal entities.
-
At Urgent Care, He Got 5 Stitches and a Big Surprise: A Plastic Surgeon’s Bill for $1,040
The Biden administration is weighing how to treat urgent care clinics as part of broad regulations banning surprise, out-of-network medical bills. At the heart of the matter: What counts as an emergency?
-
12,000 Square Miles Without Obstetrics? It’s a Possibility in West Texas
Big Bend Regional Medical Center, the only hospital in a sparsely populated region of West Texas, announced that because of a nursing shortage its labor and delivery unit must close for days at a time and patients must go instead to a hospital an hour away.
-
Facing Recall, Newsom Draws Support From Health Care Allies
California Gov. Gavin Newsom faces a recall election in September, fueled in part by anger over his pandemic policies. The health care industry has ponied up more than $4.8 million so far to defend the first-term Democrat.
-
Diabetes Drug’s New Weight Loss Formula Fuels Cost-Benefit Debate
Health plans’ coverage of the medication, branded as Wegovy — which has a $1,300-a-month price tag — is not a sure thing.
-
Pfizer Court Fight Could Legalize Medicare Copays and Unleash ‘Gold Rush’ in Sales
Pharmaceutical companies routinely cover the cost of patient copays for expensive drugs under private insurance. A federal judge could make the practice legal for millions on Medicare as well.
By Jay Hancock